Use of the plaque assay for testing the antibiotic susceptibility of intracellular bacteria

Future Microbiology

Volumn 8, Issue 10, 2013, Pages 1301-1316

  Edouard, Sophie ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

antibiotic; Coxiella burnetii; intracellular bacteria; plaque assay; Rickettsia; statin; toxin; virulence

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; DEXAMETHASONE; DEXTRAN SULFATE; DILUENT; DOXYCYCLINE; EMETINE; GENTAMICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; KETOCONAZOLE; MEVINOLIN; OMEPRAZOLE; PENTAMIDINE; PRAVASTATIN; QUINOLONE DERIVATIVE; SULFONAMIDE; THIAMPHENICOL; VIRULENCE FACTOR;

ACTIN POLYMERIZATION; ADSORPTION; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; APOPTOSIS; BACTERIAL GROWTH; BACTERIUM ISOLATION; BIOSYNTHESIS; BOUTONNEUSE FEVER; CELL DAMAGE; CELL METABOLISM; CELL TYPE; CENTRIFUGATION; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CHOLESTEROL SYNTHESIS; COXIELLA BURNETII; CYSTIC FIBROSIS; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; EYE INFECTION; GENE EXPRESSION; GRAVITY; HOSPITAL INFECTION; HOST CELL; HUMAN; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; INCUBATION TEMPERATURE; INOCULATION; INTRACELLULAR BACTERIUM; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LISTERIA MONOCYTOGENES; LYMPHOGRANULOMA VENEREUM; LYSOSOME; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGY; MUTAGENESIS; NONHUMAN; ORIENTIA TSUTSUGAMUSHI; ORNITHOSIS; PATHOGENICITY; PHAGOLYSOSOME; PHENOTYPE; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; Q FEVER; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT INFECTION; REVIEW; RICKETTSIA AFRICAE; RICKETTSIA CONORII; RICKETTSIA PARKERI; RICKETTSIA PROWAZEKII; RICKETTSIA RAOULTII; RICKETTSIA RICKETTSII; RICKETTSIA SIBIRICA; RICKETTSIA SLOVACA; RICKETTSIA TYPHI; RICKETTSIOSIS; SCRUB TYPHUS; SEXUALLY TRANSMITTED DISEASE; SHIGELLA BOYDII; SHIGELLA FLEXNERI; SHIGELLA SONNEI; TISSUE CULTURE; VENTILATOR ASSOCIATED PNEUMONIA; VERO CELL; VIRUS CULTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84885015088     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.98     Document Type: Review

References (88)

1. Kozikowski EH, Hahon N. Plaque formation by psittacosis virus. J. Bacteriol. 88, 533-553 (1964).
2. Wike DA, Tallent G, Peacock MG, Ormsbee RA. Studies of the rickettsial plaque assay technique. Infect. Immun. 5(5), 715-722 (1972).
3. Kordova N. Plaque assay of rickettsiae. Acta Virol. 10(3), 278 (1966).
4. Weinberg EH, Stakebake JR, Gerone PJ. Plaque assay for Rickettsia rickettsii. J. Bacteriol. 98(2), 398-402 (1969).
5. McDade JE. Determination of antibiotic susceptibility of Rickettsia by the plaque assay technique. Appl. Microbiol. 18(1), 133-135 (1969).
6. Oaks EV, Wingfield ME, Formal SB. Plaque formation by virulent Shigella flexneri. Infect. Immun. 48(1), 124-129 (1985).
7. Botelho-Nevers E, Rolain JM, Espinosa L, Raoult D. Statins limit Rickettsia conorii infection in cells. Int. J. Antimicrob. Agents 32(4), 344-348 (2008).
8. Audoly G, Vincentelli R, Edouard S et al. Effect of rickettsial toxin VapC on its eukaryotic host. PLoS ONE 6(10), e26528 (2011).
9. Gray MJ, Zadoks RN, Fortes ED et al. Listeria monocytogenes isolates from foods and humans form distinct but overlapping populations. Appl. Environ. Microbiol. 70(10), 5833-5841 (2004).
10. Botelho-Nevers E, Edouard S, Leroy Q, Raoult D. Deleterious effect of ciprofloxacin on Rickettsia conorii-infected cells is linked to toxin-antitoxin module up-regulation. J. Antimicrob. Chemother. 67(7), 1677-1682 (2012).
11. Oaks SC Jr, Osterman JV, Hetrick FM. Plaque assay and cloning of scrub typhus rickettsiae in irradiated L-929 cells. J. Clin. Microbiol. 6(1), 76-80 (1977).
12. Fernandez RC, Lee SH, Haldane D, Sumarah R, Rozee KR. Plaque assay for virulent Legionella pneumophila. J. Clin. Microbiol. 27(9), 1961-1964 (1989).
13. Sun AN, Camilli A, Portnoy DA. Isolation of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect. Immun. 58(11), 3770-3778 (1990).
14. McDade JE, Gerone PJ. Plaque assay for Q fever and scrub typhus rickettsiae. Appl. Microbiol. 19(6), 963-965 (1970).
15. Piraino F. Plaque formation in chick embryo fibroblast cells by Chlamydia isolated from avian and mammalian sources. J. Bacteriol. 98(2), 475-480 (1969).
16. Fournier PE, Raoult D. Current knowledge on phylogeny and taxonomy of Rickettsia spp. Ann. NY Acad Sci. 1166, 1-11 (2009).
17. Bernardini ML, Mounier J, d'Hauteville H, Coquis-Rondon M, Sansonetti PJ. Identification of icsA, a plasmid locus of Shigella flexneri that governs bacterial intra-and intercellular spread through interaction with F-actin. Proc. Natl Acad. Sci. USA 86(10), 3867-3871 (1989).
18. Kuhn M, Prevost MC, Mounier J, Sansonetti PJ. A nonvirulent mutant of Listeria monocytogenes does not move intracellularly but still induces polymerization of actin. Infect. Immun. 58(11), 3477-3486 (1989).
19. Hanson B. Improved plaque assay for Rickettsia tsutsugamushi. Am. J. Trop. Med. Hyg. 36(3), 631-638 (1987).
20. Rolain JM, Maurin M, Vestris G, Raoult D. In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials. Antimicrob. Agents Chemother. 42(7), 1537-1541 (1998).
21. Raoult D, Roussellier P, Tamalet J. In vitro evaluation of josamycin, spiramycin, and erythromycin against Rickettsia rickettsii and R. conorii. Antimicrob. Agents Chemother. 32(2), 255-256 (1988).
22. Van Langendonck N, Bottreau E, Bailly S et al. Tissue culture assays using Caco-2 cell line differentiate virulent from non-virulent Listeria monocytogenes strains. J. Appl. Microbiol. 85(2), 337-346 (1998).
23. Kastner R, Dussurget O, Archambaud C et al. LipA, a tyrosine and lipid phosphatase involved in the virulence of Listeria monocytogenes. Infect. Immun. 79(6), 2489-2498 (2011).
24. Ramsey KH, Sigar IM, Schripsema JH et al. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect. Immun. 77(8), 3284-3293 (2009).
25. Mimuro H, Suzuki T, Suetsugu S, Miki H, Takenawa T, Sasakawa C. Profilin is required for sustaining efficient intra-and intercellular spreading of Shigella flexneri. J. Biol. Chem. 275(37), 28893-28901 (2000).
26. Ohya K, Handa Y, Ogawa M, Suzuki M, Sasakawa C. IpgB1 is a novel Shigella effector protein involved in bacterial invasion of host cells. Its activity to promote membrane ruffling via Rac1 and Cdc42 activation. J. Biol. Chem. 280(25), 24022-24034 (2005).
27. Balraj P, El Karkouri K, Vestris G, Espinosa L, Raoult D, Renesto P. RickA expression is not sufficient to promote actin-based motility of Rickettsia raoultii. PLoS ONE 3(7), e2582 (2008).
28. Johnson JW, Pedersen CE Jr. Plaque formation by strains of spotted fever rickettsiae in monolayer cultures of various cell types. J. Clin. Microbiol. 7(4), 389-391 (1978).
29. Osterman JV, Parr RP. Plaque formation by Rickettsia conorii in WI-38, DBS-FRhL-2, L-929, HeLa, and chicken embryo cells. Infect. Immun. 10(5), 1152-1155 (1974).
30. Banks J, Eddie B, Schachter J, Meyer KF. Plaque formation by Chlamydia in L cells. Infect. Immun. 1(3), 259-262 (1970).
31. Piraino F, Abel C. Plaque assay for Psittacosis virus in monolayers of chick embryo fibroblasts. J. Bacteriol. 87, 1503-1511 (1964).
32. Cory J, Yunker CE, Ormsbee RA, Peacock M, Meibos H, Tallent G. Plaque assay of rickettsiae in a mammalian cell line. Appl. Microbiol. 27(6), 1157-1161 (1974).
33. Wike DA, Ormsbee RA, Tallent G, Peacock MG. Effects of various suspending media on plaque formation by rickettsiae in tissue culture. Infect. Immun. 6(4), 550-556 (1972).
34. Bovarnick MR, Miller JC, Snyder JC. The influence of certain salts, amino acids, sugars, and proteins on the stability of rickettsiae. J. Bacteriol. 59(4), 509-522 (1950).
35. Woodman DR, Grays R, Weiss E. Improved chicken embryo cell culture plaque assay for scrub typhus rickettsiae. J. Clin. Microbiol. 6(6), 639-641 (1977).
36. Policastro PF, Peacock MG, Hackstadt T. Improved plaque assays for Rickettsia prowazekii in Vero 76 cells. J. Clin. Microbiol. 34(8), 1944-1948 (1996).
37. Clark TR, Lackey AM, Kleba B et al. Transformation frequency of a mariner-based transposon in Rickettsia rickettsii. J. Bacteriol. 193(18), 4993-4995 (2011).
38. Kleba B, Clark TR, Lutter EI, Ellison DW, Hackstadt T. Disruption of the Rickettsia rickettsii Sca2 autotransporter inhibits actin-based motility. Infect. Immun. 78(5), 2240-2247 (2010).
39. Binet R, Maurelli AT. Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation. Proc. Natl Acad. Sci. USA 106(1), 292-297 (2009).
40. Merhej V, Raoult D. Rickettsial evolution in the light of comparative genomics. Biol. Rev. Camb. Philos. Soc. 86(2), 379-405 (2010).
41. Fournier PE, Belghazi L, Robert C et al. Variations of plasmid content in Rickettsia felis. PLoS ONE 3(5), e2289 (2008).
42. Haglund CM, Choe JE, Skau CT, Kovar DR, Welch MD. Rickettsia Sca2 is a bacterial formin-like mediator of actin-based motility. Nat. Cell. Biol. 12(11), 1057-1063 (2010).
43. Cory J, Yunker CE. Rickettsial plaques in mosquito cell monolayers. Acta Virol. 18(6), 512-513 (1974).
44. Raoult D, Roussellier P, Vestris G, Tamalet J. In vitro antibiotic susceptibility of Rickettsia rickettsii and Rickettsia conorii: plaque assay and microplaque colorimetric assay. J. Infect. Dis. 155(5), 1059-1062 (1987).
45. Rolain JM, Stuhl L, Maurin M, Raoult D. Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay. Antimicrob. Agents Chemother. 46(9), 2747-2751 (2002).
46. Eremeeva ME, Dasch GA, Silverman DJ. Evaluation of a PCR assay for quantitation of Rickettsia rickettsii and closely related spotted fever group rickettsiae. J. Clin. Microbiol. 41(12), 5466-5472 (2003).
47. Clark TR, Ellison DW, Kleba B, Hackstadt T. Complementation of Rickettsia rickettsii RelA/SpoT restores a nonlytic plaque phenotype. Infect. Immun. 79(4), 1631-1637 (2011).
48. Wike DA, Burgdorfer W. Plaque formation in tissue cultures by Rickettsia rickettsii isolated directly from whole blood and tick hemolymph. Infect. Immun. 6(5), 736-738 (1972).
49. Wisseman CL Jr, Waddell AD, Walsh WT. In vitro studies of the action of antibiotics on Rickettsia prowazekii by two basic methods of cell culture. J. Infect. Dis. 130(6), 564-574 (1974).
50. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect. Dis. 7(5), 358-368 (2007).
51. Wisseman CL, Waddell AD, Walsh WT. Mechanisms of immunity in typhus infections. IV. Failure of chicken embryo cells in culture to restrict growth of antibody-sensitized Rickettsia prowazekii. Infect. Immun. 9(3), 571-575 (1974).
52. Kenyon RH, McManus AT. Rickettsial infectious antibody complexes: detection by antiglobulin plaque reduction technique. Infect. Immun. 9(5), 966-968 (1974).
53. Eremeeva ME, Dasch GA, Silverman DJ. Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii. Clin. Diagn. Lab. Immunol. 8(4), 788-796 (2001).
54. Chan YG, Riley SP, Martinez JJ. Adherence to and invasion of host cells by spotted fever group Rickettsia species. Front. Microbiol. 1, 139 (2010).
55. Childs JE, Paddock CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky mountain spotted fever: is there more to learn? Am. J. Trop. Med. Hyg. 66(5), 450-457 (2002).
56. Workman FB, Hightower JA, Borges FJ, Furman JE, Parker RT. Cortisone as an adjunct to chloramphenicol in the treatment of Rocky mountain spotted fever. N. Engl. J. Med. 246(25), 962-966 (1952).
57. Botelho-Nevers E, Rovery C, Richet H, Raoult D. Analysis of risk factors for malignant Mediterranean spotted fever indicates that fluoroquinolone treatment has a deleterious effect. J. Antimicrob. Chemother. 66(8), 1821-1830 (2011).
58. Beare PA, Howe D, Cockrell DC, Heinzen RA. Efficient method of cloning the obligate intracellular bacterium Coxiella burnetii. Appl. Environ. Microbiol. 73(12), 4048-4054 (2007).
59. Rolain JM, Lambert F, Raoult D. Activity of telithromycin against thirteen new isolates of C. burnetii including three resistant to doxycycline. Ann. NY Acad. Sci. 1063, 252-256 (2005).
60. Botelho-Nevers E, Espinosa L, Raoult D, Rolain JM. Lovastatin, but not pravastatin, limits in vitro infection due to Coxiella burnetii. J. Antimicrob. Chemother. 62(4), 845-847 (2008).
61. Howe D, Heinzen RA. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism. Cell. Microbiol. 8(3), 496-507 (2006).
62. Minnick MF, Hicks LD, Battisti JM, Raghavan R. Pentamidine inhibits Coxiella burnetii growth and 23S rRNA intron splicing in vitro. Int. J. Antimicrob. Agents 36(4), 380-382 (2010).
63. Botelho-Nevers E, Singh S, Chiche L, Raoult D. Effect of omeprazole on vacuole size in Coxiella burnetii-infected cells. J. Infect. 66(3), 288-289 (2013).
64. Hanson B. Susceptibility of Rickettsia tsutsugamushi Gilliam to g interferon in cultured mouse cells. Infect. Immun. 59(11), 4125-4133 (1991).
65. Kelly DJ, Salata KF, Strickman D, Hershey JN. Rickettsia tsutsugamushi infection in cell culture: antibiotic susceptibility determined by flow cytometry. Am. J. Trop. Med. Hyg. 53(6), 602-606 (1995).
66. Tantibhedhyangkul W, Angelakis E, Tongyoo N et al. Intrinsic fluoroquinolone resistance in Orientia tsutsugamushi. Int. J. Antimicrob. Agents 35(4), 338-341 (2010).
67. Dautry-Varsat A, Subtil A, Hackstadt T. Recent insights into the mechanisms of Chlamydia entry. Cell Microbiol. 7(12), 1714-1722 (2005).
68. Higashi N, Tamura A. A plaque assay for meningopneumonitis virus in monolayers of strain L cells. Virology 12, 578-588 (1960).
69. Bernkoff H. A plaque test for TRIC agents. Am. J. Ophthalmol. 63(5 Suppl.), 1206-1211. (1967).
70. Matsumoto A, Izutsu H, Miyashita N, Ohuchi M. Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J. Clin. Microbiol. 36(10), 3013-3019 (1998).
71. Binet R, Maurelli AT. Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp. Antimicrob. Agents Chemother. 49(7), 2865-2873 (2005).
72. Kari L, Goheen MM, Randall LB et al. Generation of targeted Chlamydia trachomatis null mutants. Proc. Natl Acad. Sci. USA 108(17), 7189-7193 (2011).
73. Binet R, Maurelli AT. The chlamydial functional homolog of KsgA confers kasugamycin sensitivity to Chlamydia trachomatis and impacts bacterial fitness. BMC Microbiol. 9, 279 (2009).
74. Maurin M, Raoult D. Phagolysosomal alkalinization and intracellular killing of Staphylococcus aureus by amikacin. J. Infect. Dis. 169(2), 330-336 (1994).
75. Garduno RA, Garduno E, Hiltz M, Hoffman PS. Intracellular growth of Legionella pneumophila gives rise to a differentiated form dissimilar to stationary-phase forms. Infect. Immun. 70(11), 6273-6283 (2002).
76. Day SR, Sifri CD, Hoffman PS. Infection of nonphagocytic host cells by Legionella. Methods Mol. Biol. 954, 463-478 (2013).
77. Shevchuk O, Steinert M. Screening of virulence traits in Legionella pneumophila and analysis of the host susceptibility to infection by using the Dictyostelium host model system. Methods Mol. Biol. 470, 47-56 (2009).
78. Jeong HJ, Jang ES, Han BI et al. Acanthamoeba: could it be an environmental host of Shigella? Exp. Parasitol. 115(2), 181-186 (2007).
79. Cersini A, Salvia AM, Bernardini ML. Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect. Immun. 66(2), 549-557 (1998).
80. Sharma AK, Payne SM. Induction of expression of hfq by DksA is essential for Shigella flexneri virulence. Mol. Microbiol. 62(2), 469-479 (2006).
81. Wu T, Grassel C, Levine MM, Barry EM. Live attenuated Shigella dysenteriae type 1 vaccine strains overexpressing shiga toxin B subunit. Infect. Immun. 79(12), 4912-4922 (2011).
82. Purdy GE, Fisher CR, Payne SM. IcsA surface presentation in Shigella flexneri requires the periplasmic chaperones DegP, Skp, and SurA. J. Bacteriol. 189(15), 5566-5573 (2007).
83. Hong M, Gleason Y, Wyckoff EE, Payne SM. Identification of two Shigella flexneri chromosomal loci involved in intercellular spreading. Infect. Immun. 66(10), 4700-4710 (1998).
84. Boulette ML, Payne SM. Anaerobic regulation of Shigella flexneri virulence: ArcA regulates Fur and iron acquisition genes. J. Bacteriol. 189(19), 6957-6967 (2007).
85. Mills JA, Buysse JM, Oaks EV. Shigella flexneri invasion plasmid antigens B and C: epitope location and characterization with monoclonal antibodies. Infect. Immun. 56(11), 2933-2941 (1988).
86. Roche SM, Velge P, Bottreau E, Durier C, Marquet-van der Mee N, Pardon P. Assessment of the virulence of Listeria monocytogenes: agreement between a plaque-forming assay with HT-29 cells and infection of immunocompetent mice. Int. J. Food Microbiol. 68(1-2), 33-44 (2001).
87. Neves E, Silva AC, Roche SM, Velge P, Brito L. Virulence of Listeria monocytogenes isolated from the cheese dairy environment, other foods and clinical cases. J. Med. Microbiol. 57(Pt 4), 411-415 (2008).
88. Fenner L, Richet H, Raoult D, Papazian L, Martin C, La Scola B. Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test? Crit. Care Med. 34(3), 823-828 (2006).